首页 > 最新文献

Frontiers in Medical Technology最新文献

英文 中文
Case Report: Endoscopic radiofrequency ablation with radial-EBUS and ROSE. 病例报告:内镜射频消融与放射状ebus和ROSE。
Pub Date : 2023-01-01 DOI: 10.3389/fmedt.2023.1022220
Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Vasileios Papadopoulos, Eleni-Isidora Perdikouri, Nikolaos Courcoutsakis, Konstantinos Porpodis, Dimitrios Matthaios, Kostas Trigonakis

Background: Single pulmonary nodules are a common issue in everyday clinical practice. Currently, there are navigation systems with radial-endobronchial ultrasound and electromagnetic navigation for obtaining biopsies. Moreover, rapid on-site evaluation can be used for a quick assessment. These small lesions, even when they do not have any clinically significant information with positron emission tomography, are important to investigate.

Case description: Radiofrequency and microwave ablation have been evaluated as local treatment techniques. These techniques can be used as therapy for a patient population that cannot be operated on. Currently, one verified operating system is used for endoscopic radiofrequency ablation through the working channel of a bronchoscope.

Conclusion: In our case, a new system was used to perform radiofrequency ablation with long-term follow-up.

背景:在日常临床实践中,单肺结节是一个常见的问题。目前,有放射状支气管内超声和电磁导航的导航系统用于活检。此外,快速现场评估可以用于快速评估。这些小病变,即使它们没有任何临床意义的信息与正电子发射断层扫描,是重要的研究。病例描述:射频和微波消融已被评估为局部治疗技术。这些技术可用于治疗不能进行手术的患者群体。目前,一种经过验证的操作系统被用于通过支气管镜的工作通道进行内窥镜射频消融。结论:在我们的病例中,采用了一种新的系统进行射频消融并进行长期随访。
{"title":"Case Report: Endoscopic radiofrequency ablation with radial-EBUS and ROSE.","authors":"Paul Zarogoulidis,&nbsp;Wolfgang Hohenforst-Schmidt,&nbsp;Vasileios Papadopoulos,&nbsp;Eleni-Isidora Perdikouri,&nbsp;Nikolaos Courcoutsakis,&nbsp;Konstantinos Porpodis,&nbsp;Dimitrios Matthaios,&nbsp;Kostas Trigonakis","doi":"10.3389/fmedt.2023.1022220","DOIUrl":"https://doi.org/10.3389/fmedt.2023.1022220","url":null,"abstract":"<p><strong>Background: </strong>Single pulmonary nodules are a common issue in everyday clinical practice. Currently, there are navigation systems with radial-endobronchial ultrasound and electromagnetic navigation for obtaining biopsies. Moreover, rapid on-site evaluation can be used for a quick assessment. These small lesions, even when they do not have any clinically significant information with positron emission tomography, are important to investigate.</p><p><strong>Case description: </strong>Radiofrequency and microwave ablation have been evaluated as local treatment techniques. These techniques can be used as therapy for a patient population that cannot be operated on. Currently, one verified operating system is used for endoscopic radiofrequency ablation through the working channel of a bronchoscope.</p><p><strong>Conclusion: </strong>In our case, a new system was used to perform radiofrequency ablation with long-term follow-up.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"5 ","pages":"1022220"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10661250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding a videogame home intervention for children with hemiplegia: a mixed methods multi-case study. 了解电子游戏对偏瘫儿童的家庭干预:一项混合方法的多案例研究。
Pub Date : 2023-01-01 DOI: 10.3389/fmedt.2023.1217797
Daniela Chan-Víquez, Ajmal Khan, Sarah Munce, Darcy Fehlings, F Virginia Wright, Elaine Biddiss

Introduction: Access to rehabilitation therapies is a salient and growing issue for children with cerebral palsy (CP) and their families, motivating interest in home-based interventions. Bootle Blast is a low-cost, movement-tracking videogame that can be used at home to encourage upper limb (UL) functional exercise tailored to each child's abilities and therapy goals. The study objectives were to: 1) Establish the extent to which children achieve their self-directed play-time goal over a 12-week intervention, 2) Measure changes in UL motor outcomes, and 3) Explore participants' experiences of using Bootle Blast at home.

Methods: Mixed methods case series study of four children with hemiplegic cerebral palsy (HCP), each with a participating parent. Participants played Bootle Blast at home for 12 weeks. Study assessments occurred at baseline, post-intervention and four week follow up. A post-intervention interview explored participants' experiences. Game-logs provided play time and progress data.

Results: Three of four participants (8-13 yrs., Manual Ability Classification Level I-II) completed the intervention. One dropped out at week 6. Play-time goals were achieved in most weeks, with two of four children surpassing their overall intervention goals. Outcomes varied across the three participants, however consistent improvements were observed on the Canadian Occupational Performance Measure and the Box and Blocks Test. Inductive analysis generated four main themes: 1) Intrinsic motivators fostered play engagement, 2) Virtual play for real-world gains, 3) Therapy on demand (at home), and 4) Shifting the onus from the parent to the game. Integration of qualitative and quantitative data was important for interpreting play patterns/usage and clinical outcomes.

Discussion: This mixed methods study describes a novel videogaming intervention designed for home-rehabilitation for children with HCP and provides preliminary evidence to guide future study design and research.

Clinical trial registration: [https://clinicaltrials.gov/ct2/show/NCT04009031?recrs=h&cond=Cerebral+Palsy&cntry=CA&city=Toronto&draw=2&rank=1], identifier [NCT04009031].

获得康复治疗是脑瘫儿童及其家庭面临的一个日益突出的问题,这激发了人们对家庭干预的兴趣。Bootle Blast是一款低成本的运动追踪视频游戏,可以在家里使用,鼓励根据每个孩子的能力和治疗目标量身定制上肢功能锻炼。研究的目的是:1)确定儿童在12周的干预中实现自我指导的游戏时间目标的程度,2)测量UL运动结果的变化,以及3)探索参与者在家使用Bootle Blast的体验。方法:采用混合方法对4例偏瘫性脑瘫(HCP)患儿进行病例系列研究。参与者在家玩了12周的《Bootle Blast》。研究评估在基线、干预后和四周随访时进行。干预后的访谈探讨了参与者的经历。游戏日志提供了游戏时间和进程数据。结果:3 / 4的参与者(8-13岁)。, Manual Ability Classification Level I-II)完成干预。其中一人在第6周退出。玩耍时间目标在大多数周内都达到了,四个孩子中有两个超过了他们的总体干预目标。三个参与者的结果各不相同,但在加拿大职业表现测量和方框和块测试中观察到一致的改善。归纳分析产生了四个主要主题:1)内在动机促进游戏粘性,2)虚拟游戏获得现实世界的收益,3)治疗需求(在家),4)将责任从父母转移到游戏中。定性和定量数据的整合对于解释游戏模式/使用情况和临床结果非常重要。讨论:这项混合方法的研究描述了一种新的视频游戏干预,旨在为HCP儿童的家庭康复设计,并为指导未来的研究设计和研究提供初步证据。临床试验注册:[https://clinicaltrials.gov/ct2/show/NCT04009031?recrs=h&cond=Cerebral+Palsy&cntry=CA&city=Toronto&draw=2&rank=1],标识符[NCT04009031]。
{"title":"Understanding a videogame home intervention for children with hemiplegia: a mixed methods multi-case study.","authors":"Daniela Chan-Víquez,&nbsp;Ajmal Khan,&nbsp;Sarah Munce,&nbsp;Darcy Fehlings,&nbsp;F Virginia Wright,&nbsp;Elaine Biddiss","doi":"10.3389/fmedt.2023.1217797","DOIUrl":"https://doi.org/10.3389/fmedt.2023.1217797","url":null,"abstract":"<p><strong>Introduction: </strong>Access to rehabilitation therapies is a salient and growing issue for children with cerebral palsy (CP) and their families, motivating interest in home-based interventions. Bootle Blast is a low-cost, movement-tracking videogame that can be used at home to encourage upper limb (UL) functional exercise tailored to each child's abilities and therapy goals. The study objectives were to: 1) Establish the extent to which children achieve their self-directed play-time goal over a 12-week intervention, 2) Measure changes in UL motor outcomes, and 3) Explore participants' experiences of using Bootle Blast at home.</p><p><strong>Methods: </strong>Mixed methods case series study of four children with hemiplegic cerebral palsy (HCP), each with a participating parent. Participants played Bootle Blast at home for 12 weeks. Study assessments occurred at baseline, post-intervention and four week follow up. A post-intervention interview explored participants' experiences. Game-logs provided play time and progress data.</p><p><strong>Results: </strong>Three of four participants (8-13 yrs., Manual Ability Classification Level I-II) completed the intervention. One dropped out at week 6. Play-time goals were achieved in most weeks, with two of four children surpassing their overall intervention goals. Outcomes varied across the three participants, however consistent improvements were observed on the Canadian Occupational Performance Measure and the Box and Blocks Test. Inductive analysis generated four main themes: 1) Intrinsic motivators fostered play engagement, 2) Virtual play for real-world gains, 3) Therapy on demand (at home), and 4) Shifting the onus from the parent to the game. Integration of qualitative and quantitative data was important for interpreting play patterns/usage and clinical outcomes.</p><p><strong>Discussion: </strong>This mixed methods study describes a novel videogaming intervention designed for home-rehabilitation for children with HCP and provides preliminary evidence to guide future study design and research.</p><p><strong>Clinical trial registration: </strong>[https://clinicaltrials.gov/ct2/show/NCT04009031?recrs=h&cond=Cerebral+Palsy&cntry=CA&city=Toronto&draw=2&rank=1], identifier [NCT04009031].</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"5 ","pages":"1217797"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10263725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biosynthesized nanoparticles: a novel approach for cancer therapeutics. 生物合成纳米颗粒:癌症治疗的新方法。
Pub Date : 2023-01-01 DOI: 10.3389/fmedt.2023.1236107
Vivek K Chaturvedi, Bhaskar Sharma, Abhay Dev Tripathi, Dawesh P Yadav, Kshitij Rb Singh, Jay Singh, Ravindra Pratap Singh

Nanotechnology has become one of the most rapid, innovative, and adaptable sciences in modern science and cancer therapy. Traditional chemotherapy has limits owing to its non-specific nature and adverse side effects on healthy cells, and it remains a serious worldwide health issue. Because of their capacity to specifically target cancer cells and deliver therapeutic chemicals directly to them, nanoparticles have emerged as a viable strategy for cancer therapies. Nanomaterials disclose novel properties based on size, distribution, and shape. Biosynthesized or biogenic nanoparticles are a novel technique with anti-cancer capabilities, such as triggering apoptosis in cancer cells and slowing tumour growth. They may be configured to deliver medications or other therapies to specific cancer cells or tumour markers. Despite their potential, biosynthesized nanoparticles confront development obstacles such as a lack of standardisation in their synthesis and characterization, the possibility of toxicity, and their efficiency against various forms of cancer. The effectiveness and safety of biosynthesized nanoparticles must be further investigated, as well as the types of cancer they are most successful against. This review discusses the promise of biosynthesized nanoparticles as a novel approach for cancer therapeutics, as well as their mode of action and present barriers to their development.

纳米技术已经成为现代科学和癌症治疗中最快速、创新和适应性最强的科学之一。传统化疗由于其非特异性和对健康细胞的不良副作用而具有局限性,并且仍然是一个严重的全球健康问题。由于纳米颗粒具有特异性靶向癌细胞并直接向其输送治疗化学物质的能力,因此它们已成为癌症治疗的一种可行策略。纳米材料揭示了基于尺寸、分布和形状的新特性。生物合成或生物源纳米颗粒是一种具有抗癌能力的新技术,如触发癌细胞凋亡和减缓肿瘤生长。它们可以被配置为向特定的癌细胞或肿瘤标志物输送药物或其他疗法。尽管具有潜力,生物合成纳米粒子仍面临着发展障碍,如合成和表征方面缺乏标准化,可能存在毒性,以及它们对各种癌症的有效性。生物合成纳米颗粒的有效性和安全性,以及它们最成功对抗的癌症类型,都必须进一步研究。这篇综述讨论了生物合成纳米颗粒作为一种新的癌症治疗方法的前景,以及它们的作用模式和目前发展的障碍。
{"title":"Biosynthesized nanoparticles: a novel approach for cancer therapeutics.","authors":"Vivek K Chaturvedi,&nbsp;Bhaskar Sharma,&nbsp;Abhay Dev Tripathi,&nbsp;Dawesh P Yadav,&nbsp;Kshitij Rb Singh,&nbsp;Jay Singh,&nbsp;Ravindra Pratap Singh","doi":"10.3389/fmedt.2023.1236107","DOIUrl":"https://doi.org/10.3389/fmedt.2023.1236107","url":null,"abstract":"<p><p>Nanotechnology has become one of the most rapid, innovative, and adaptable sciences in modern science and cancer therapy. Traditional chemotherapy has limits owing to its non-specific nature and adverse side effects on healthy cells, and it remains a serious worldwide health issue. Because of their capacity to specifically target cancer cells and deliver therapeutic chemicals directly to them, nanoparticles have emerged as a viable strategy for cancer therapies. Nanomaterials disclose novel properties based on size, distribution, and shape. Biosynthesized or biogenic nanoparticles are a novel technique with anti-cancer capabilities, such as triggering apoptosis in cancer cells and slowing tumour growth. They may be configured to deliver medications or other therapies to specific cancer cells or tumour markers. Despite their potential, biosynthesized nanoparticles confront development obstacles such as a lack of standardisation in their synthesis and characterization, the possibility of toxicity, and their efficiency against various forms of cancer. The effectiveness and safety of biosynthesized nanoparticles must be further investigated, as well as the types of cancer they are most successful against. This review discusses the promise of biosynthesized nanoparticles as a novel approach for cancer therapeutics, as well as their mode of action and present barriers to their development.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"5 ","pages":"1236107"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10268382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applications. 研究可储存和随时使用的人造红细胞(血红蛋白囊泡),用于急救医学和其他临床应用。
Pub Date : 2022-12-23 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.1048951
Hiromi Sakai, Tomoko Kure, Kazuaki Taguchi, Hiroshi Azuma

Hemoglobin (Hb) is the most abundant protein in blood, with concentration of about 12-15 g/dl. The highly concentrated Hb solution (35 g/dl) is compartmentalized in red blood cells (RBCs). Once Hb is released from RBCs by hemolysis during blood circulation, it induces renal and cardiovascular toxicities. To date, hemoglobin-based oxygen carriers of various types have been developed as blood substitutes to mitigate the Hb toxicities. One method is Hb encapsulation in phospholipid vesicles (liposomes). Although the Hb toxicity can be shielded, it is equally important to ensure the biocompatibility of the liposomal membrane. We have developed Hb-vesicles (HbV). A new encapsulation method using a rotation-revolution mixer which enabled efficient production of HbV with a high yield has considerably facilitated R&D of HbV. Along with our academic consortium, we have studied the preclinical safety and efficacy of HbV extensively as a transfusion alternative, and finally conducted a phase I clinical trial. Moreover, carbonyl-HbV and met-HbV are developed respectively for an anti-inflammatory and anti-oxidative agent and an antidote for poisons. This review paper specifically presents past trials of liposome encapsulated Hb, biocompatible lipid bilayer membranes, and efficient HbV preparation methods, in addition to potential clinical applications of HbV based on results of our in vivo studies.

血红蛋白(Hb)是血液中含量最高的蛋白质,浓度约为 12-15 克/分升。高浓度的 Hb 溶液(35 克/分升)被分隔在红细胞(RBC)中。一旦血红蛋白在血液循环过程中因溶血作用从红细胞中释放出来,就会引起肾脏和心血管中毒。迄今为止,已开发出各种基于血红蛋白的氧气载体,作为血液替代品来减轻 Hb 的毒性。其中一种方法是将血红蛋白封装在磷脂囊(脂质体)中。虽然可以避免血红蛋白的毒性,但确保脂质体膜的生物相容性同样重要。我们开发了 Hb-囊泡 (HbV)。使用旋转-旋转混合器的新型封装方法能够高效地生产出高产率的 HbV,这大大促进了 HbV 的研发工作。我们与学术联盟一起,对 HbV 作为输血替代品的临床前安全性和有效性进行了广泛研究,并最终开展了一期临床试验。此外,我们还开发了羰基 HbV 和 met-HbV,分别用于抗炎、抗氧化和解毒。本综述论文特别介绍了脂质体包裹 Hb、生物相容性脂质双层膜和高效 HbV 制备方法的以往试验,以及基于我们的体内研究结果的 HbV 潜在临床应用。
{"title":"Research of storable and ready-to-use artificial red blood cells (hemoglobin vesicles) for emergency medicine and other clinical applications.","authors":"Hiromi Sakai, Tomoko Kure, Kazuaki Taguchi, Hiroshi Azuma","doi":"10.3389/fmedt.2022.1048951","DOIUrl":"10.3389/fmedt.2022.1048951","url":null,"abstract":"<p><p>Hemoglobin (Hb) is the most abundant protein in blood, with concentration of about 12-15 g/dl. The highly concentrated Hb solution (35 g/dl) is compartmentalized in red blood cells (RBCs). Once Hb is released from RBCs by hemolysis during blood circulation, it induces renal and cardiovascular toxicities. To date, hemoglobin-based oxygen carriers of various types have been developed as blood substitutes to mitigate the Hb toxicities. One method is Hb encapsulation in phospholipid vesicles (liposomes). Although the Hb toxicity can be shielded, it is equally important to ensure the biocompatibility of the liposomal membrane. We have developed Hb-vesicles (HbV). A new encapsulation method using a rotation-revolution mixer which enabled efficient production of HbV with a high yield has considerably facilitated R&D of HbV. Along with our academic consortium, we have studied the preclinical safety and efficacy of HbV extensively as a transfusion alternative, and finally conducted a phase I clinical trial. Moreover, carbonyl-HbV and met-HbV are developed respectively for an anti-inflammatory and anti-oxidative agent and an antidote for poisons. This review paper specifically presents past trials of liposome encapsulated Hb, biocompatible lipid bilayer membranes, and efficient HbV preparation methods, in addition to potential clinical applications of HbV based on results of our <i>in vivo</i> studies.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"4 ","pages":"1048951"},"PeriodicalIF":0.0,"publicationDate":"2022-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10564859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of artificial intelligence in orthopaedic surgery. 人工智能在矫形外科中的应用。
Pub Date : 2022-12-15 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.995526
Faraz Farhadi, Matthew R Barnes, Harun R Sugito, Jessica M Sin, Eric R Henderson, Joshua J Levy

The practice of medicine is rapidly transforming as a result of technological breakthroughs. Artificial intelligence (AI) systems are becoming more and more relevant in medicine and orthopaedic surgery as a result of the nearly exponential growth in computer processing power, cloud based computing, and development, and refining of medical-task specific software algorithms. Because of the extensive role of technologies such as medical imaging that bring high sensitivity, specificity, and positive/negative prognostic value to management of orthopaedic disorders, the field is particularly ripe for the application of machine-based integration of imaging studies, among other applications. Through this review, we seek to promote awareness in the orthopaedics community of the current accomplishments and projected uses of AI and ML as described in the literature. We summarize the current state of the art in the use of ML and AI in five key orthopaedic disciplines: joint reconstruction, spine, orthopaedic oncology, trauma, and sports medicine.

由于技术上的突破,医疗实践正在迅速发生变化。由于计算机处理能力、基于云的计算以及特定医疗任务软件算法的开发和完善几乎呈指数级增长,人工智能(AI)系统在医学和骨科手术中的作用越来越大。医学影像等技术为骨科疾病的管理带来了高灵敏度、高特异性和高阳性/阴性预后价值,因此,在该领域应用基于机器的影像研究整合及其他应用的时机尤为成熟。通过这篇综述,我们希望提高骨科界对人工智能和 ML 的当前成就和预期用途的认识,正如文献中所描述的那样。我们总结了人工智能和 ML 在五个关键骨科学科中的应用现状:关节重建、脊柱、肿瘤骨科、创伤和运动医学。
{"title":"Applications of artificial intelligence in orthopaedic surgery.","authors":"Faraz Farhadi, Matthew R Barnes, Harun R Sugito, Jessica M Sin, Eric R Henderson, Joshua J Levy","doi":"10.3389/fmedt.2022.995526","DOIUrl":"10.3389/fmedt.2022.995526","url":null,"abstract":"<p><p>The practice of medicine is rapidly transforming as a result of technological breakthroughs. Artificial intelligence (AI) systems are becoming more and more relevant in medicine and orthopaedic surgery as a result of the nearly exponential growth in computer processing power, cloud based computing, and development, and refining of medical-task specific software algorithms. Because of the extensive role of technologies such as medical imaging that bring high sensitivity, specificity, and positive/negative prognostic value to management of orthopaedic disorders, the field is particularly ripe for the application of machine-based integration of imaging studies, among other applications. Through this review, we seek to promote awareness in the orthopaedics community of the current accomplishments and projected uses of AI and ML as described in the literature. We summarize the current state of the art in the use of ML and AI in five key orthopaedic disciplines: joint reconstruction, spine, orthopaedic oncology, trauma, and sports medicine.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"4 ","pages":"995526"},"PeriodicalIF":0.0,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9255321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated finite element approach to generate anatomical patient-specific biomechanical models of atherosclerotic arteries from virtual histology-intravascular ultrasound. 从虚拟组织学-血管内超声生成动脉粥样硬化动脉解剖患者特异性生物力学模型的自动化有限元方法。
Pub Date : 2022-11-29 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.1008540
Jeremy L Warren, John E Yoo, Clark A Meyer, David S Molony, Habib Samady, Heather N Hayenga

Despite advancements in early detection and treatment, atherosclerosis remains the leading cause of death across all cardiovascular diseases (CVD). Biomechanical analysis of atherosclerotic lesions has the potential to reveal biomechanically instable or rupture-prone regions. Treatment decisions rarely consider the biomechanics of the stenosed lesion due in-part to difficulties in obtaining this information in a clinical setting. Previous 3D FEA approaches have incompletely incorporated the complex curvature of arterial geometry, material heterogeneity, and use of patient-specific data. To address these limitations and clinical need, herein we present a user-friendly fully automated program to reconstruct and simulate the wall mechanics of patient-specific atherosclerotic coronary arteries. The program enables 3D reconstruction from patient-specific data with heterogenous tissue assignment and complex arterial curvature. Eleven arteries with coronary artery disease (CAD) underwent baseline and 6-month follow-up angiographic and virtual histology-intravascular ultrasound (VH-IVUS) imaging. VH-IVUS images were processed to remove background noise, extract VH plaque material data, and luminal and outer contours. Angiography data was used to orient the artery profiles along the 3D centerlines. The resulting surface mesh is then resampled for uniformity and tetrahedralized to generate the volumetric mesh using TetGen. A mesh convergence study revealed edge lengths between 0.04 mm and 0.2 mm produced constituent volumes that were largely unchanged, hence, to save computational resources, a value of 0.2 mm was used throughout. Materials are assigned and finite element analysis (FEA) is then performed to determine stresses and strains across the artery wall. In a representative artery, the highest average effective stress was in calcium elements with 235 kPa while necrotic elements had the lowest average stress, reaching as low as 0.79 kPa. After applying nodal smoothening, the maximum effective stress across 11 arteries remained below 288 kPa, implying biomechanically stable plaques. Indeed, all atherosclerotic plaques remained unruptured at the 6-month longitudinal follow up diagnosis. These results suggest our automated analysis may facilitate assessment of atherosclerotic plaque stability.

尽管在早期发现和治疗方面取得了进展,动脉粥样硬化仍然是所有心血管疾病(CVD)的主要死亡原因。动脉粥样硬化病变的生物力学分析有可能揭示生物力学不稳定或容易破裂的区域。治疗决策很少考虑狭窄病变的生物力学,部分原因是在临床环境中难以获得这些信息。以前的三维有限元分析方法没有完全纳入动脉几何形状的复杂曲率、材料异质性和患者特定数据的使用。为了解决这些限制和临床需要,我们提出了一个用户友好的全自动程序来重建和模拟患者特定的动脉粥样硬化冠状动脉的壁力学。该程序可以从具有异质组织分配和复杂动脉曲率的患者特定数据中进行3D重建。11条冠状动脉疾病(CAD)的动脉进行了基线和6个月的随访血管造影和虚拟组织学-血管内超声(VH-IVUS)成像。对VH- ivus图像进行处理,去除背景噪声,提取VH斑块材料数据,以及腔内和外部轮廓。血管造影数据用于沿3D中心线定位动脉剖面。然后对得到的表面网格进行重新采样以确保均匀性和四面体化,从而使用TetGen生成体积网格。网格收敛研究表明,在0.04 mm和0.2 mm之间的边缘长度产生的组成体积基本上没有变化,因此,为了节省计算资源,始终使用0.2 mm的值。分配材料,然后进行有限元分析(FEA)以确定动脉壁的应力和应变。在某代表性动脉中,钙元素的平均有效应力最高,为235 kPa,坏死元素的平均有效应力最低,仅为0.79 kPa。应用结平滑后,11条动脉的最大有效应力保持在288 kPa以下,表明斑块生物力学稳定。事实上,所有动脉粥样硬化斑块在6个月的纵向随访诊断时仍未破裂。这些结果表明,我们的自动化分析可能有助于评估动脉粥样硬化斑块的稳定性。
{"title":"Automated finite element approach to generate anatomical patient-specific biomechanical models of atherosclerotic arteries from virtual histology-intravascular ultrasound.","authors":"Jeremy L Warren, John E Yoo, Clark A Meyer, David S Molony, Habib Samady, Heather N Hayenga","doi":"10.3389/fmedt.2022.1008540","DOIUrl":"10.3389/fmedt.2022.1008540","url":null,"abstract":"<p><p>Despite advancements in early detection and treatment, atherosclerosis remains the leading cause of death across all cardiovascular diseases (CVD). Biomechanical analysis of atherosclerotic lesions has the potential to reveal biomechanically instable or rupture-prone regions. Treatment decisions rarely consider the biomechanics of the stenosed lesion due in-part to difficulties in obtaining this information in a clinical setting. Previous 3D FEA approaches have incompletely incorporated the complex curvature of arterial geometry, material heterogeneity, and use of patient-specific data. To address these limitations and clinical need, herein we present a user-friendly fully automated program to reconstruct and simulate the wall mechanics of patient-specific atherosclerotic coronary arteries. The program enables 3D reconstruction from patient-specific data with heterogenous tissue assignment and complex arterial curvature. Eleven arteries with coronary artery disease (CAD) underwent baseline and 6-month follow-up angiographic and virtual histology-intravascular ultrasound (VH-IVUS) imaging. VH-IVUS images were processed to remove background noise, extract VH plaque material data, and luminal and outer contours. Angiography data was used to orient the artery profiles along the 3D centerlines. The resulting surface mesh is then resampled for uniformity and tetrahedralized to generate the volumetric mesh using TetGen. A mesh convergence study revealed edge lengths between 0.04 mm and 0.2 mm produced constituent volumes that were largely unchanged, hence, to save computational resources, a value of 0.2 mm was used throughout. Materials are assigned and finite element analysis (FEA) is then performed to determine stresses and strains across the artery wall. In a representative artery, the highest average effective stress was in calcium elements with 235 kPa while necrotic elements had the lowest average stress, reaching as low as 0.79 kPa. After applying nodal smoothening, the maximum effective stress across 11 arteries remained below 288 kPa, implying biomechanically stable plaques. Indeed, all atherosclerotic plaques remained unruptured at the 6-month longitudinal follow up diagnosis. These results suggest our automated analysis may facilitate assessment of atherosclerotic plaque stability.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"4 ","pages":"1008540"},"PeriodicalIF":0.0,"publicationDate":"2022-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10713293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capsule endoscopy in Crohn's disease surveillance: A monocentric, retrospective analysis in Italy. 克罗恩病监测中的胶囊内镜检查:意大利的单中心回顾性分析。
Pub Date : 2022-11-28 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.1038087
Carlo Calabrese, Dania Gelli, Fernando Rizzello, Paolo Gionchetti, Rafael Torrejon Torres, Rhodri Saunders, Jason Davis

Background: Crohn's disease (CD) is a potentially debilitating condition that burdens Italian healthcare substantially. The symptomatic management relies on prompt therapy adjustment to reduce flares and follow-up diagnostic inputs to maximise remission. Capsule endoscopy (CE) has introduced advantages in CD diagnostics, allowing the direct inspection of the entire gastrointestinal mucosa. The diagnostic procedure is comparable in effort to standard ileocolonoscopy (IC) but requires no anaesthesia. Whether CE follow-up improves clinical outcomes remains to be defined.

Objectives: To provide a preliminary evaluation of CE in terms of clinical outcomes with respect to the standard of care ileocolonoscopy/MRE in Italy.

Methods: This retrospective analysis utilises anonymised, monocentric data from the S. Orsola-Malpighi Hospital IBD database in Bologna, Italy, collected between 1999 and 2019. Out of 421 adult patient records, 100 were included in the analysis (50 per arm, matched per demographic and clinical characteristics). The CE represented the intervention arm, whereas ileocolonoscopy/magnetic resonance enterography was the standard of care. The use of biologics, symptomatology course, and surgery were the outcomes.

Results: The two techniques performed similarly overall. In general, no significant difference emerged in the use of biologics. The use of biologics appears reduced in the CE group, only in L4 patients after the first follow-up year. Similarly, surgery was seemingly less frequent among L4 patients in the CE group. No difference was found between groups in flare occurrence and duration. CE patients might have experienced longer and earlier first remissions, but no long-term difference persisted.

Conclusions: The CE group showed an apparent reduction in biologics and surgery, limiting to L4 diagnoses. More extensive, prospective, multicentre, randomised studies must corroborate these preliminary findings.

背景:克罗恩病(CD克罗恩病(CD)是一种可能使人衰弱的疾病,给意大利的医疗保健造成了沉重负担。对症治疗依赖于及时调整治疗方案以减少复发,以及后续诊断投入以最大限度地缓解病情。胶囊内窥镜(CE)为胃肠病诊断带来了优势,可直接检查整个胃肠道粘膜。该诊断程序的工作量与标准回肠结肠镜检查(IC)相当,但无需麻醉。CE随访是否能改善临床效果仍有待确定:方法:本回顾性分析采用了在意大利进行的无记名回肠结肠镜检查结果:这项回顾性分析采用了意大利博洛尼亚 S. Orsola-Malpighi 医院 IBD 数据库中 1999 年至 2019 年期间收集的匿名单中心数据。在 421 份成人病历中,有 100 份被纳入分析(每组 50 份,人口统计学和临床特征匹配)。CE代表干预组,而回结肠镜/磁共振肠造影则是标准护理组。结果显示了生物制剂的使用、症状病程和手术情况:结果:两种技术的总体表现相似。总的来说,生物制剂的使用没有明显差异。在 CE 组中,生物制剂的使用似乎减少了,但只有 L4 患者在第一年随访后减少了生物制剂的使用。同样,CE 组 L4 患者的手术频率似乎也较低。在复发发生率和持续时间方面,各组之间没有发现差异。CE组患者的首次缓解时间可能更长、更早,但长期差异并不存在:CE组的生物制剂和手术明显减少,但仅限于L4诊断。更广泛的前瞻性多中心随机研究必须证实这些初步发现。
{"title":"Capsule endoscopy in Crohn's disease surveillance: A monocentric, retrospective analysis in Italy.","authors":"Carlo Calabrese, Dania Gelli, Fernando Rizzello, Paolo Gionchetti, Rafael Torrejon Torres, Rhodri Saunders, Jason Davis","doi":"10.3389/fmedt.2022.1038087","DOIUrl":"10.3389/fmedt.2022.1038087","url":null,"abstract":"<p><strong>Background: </strong>Crohn's disease (CD) is a potentially debilitating condition that burdens Italian healthcare substantially. The symptomatic management relies on prompt therapy adjustment to reduce flares and follow-up diagnostic inputs to maximise remission. Capsule endoscopy (CE) has introduced advantages in CD diagnostics, allowing the direct inspection of the entire gastrointestinal mucosa. The diagnostic procedure is comparable in effort to standard ileocolonoscopy (IC) but requires no anaesthesia. Whether CE follow-up improves clinical outcomes remains to be defined.</p><p><strong>Objectives: </strong>To provide a preliminary evaluation of CE in terms of clinical outcomes with respect to the standard of care ileocolonoscopy/MRE in Italy.</p><p><strong>Methods: </strong>This retrospective analysis utilises anonymised, monocentric data from the S. Orsola-Malpighi Hospital IBD database in Bologna, Italy, collected between 1999 and 2019. Out of 421 adult patient records, 100 were included in the analysis (50 per arm, matched per demographic and clinical characteristics). The CE represented the intervention arm, whereas ileocolonoscopy/magnetic resonance enterography was the standard of care. The use of biologics, symptomatology course, and surgery were the outcomes.</p><p><strong>Results: </strong>The two techniques performed similarly overall. In general, no significant difference emerged in the use of biologics. The use of biologics appears reduced in the CE group, only in L4 patients after the first follow-up year. Similarly, surgery was seemingly less frequent among L4 patients in the CE group. No difference was found between groups in flare occurrence and duration. CE patients might have experienced longer and earlier first remissions, but no long-term difference persisted.</p><p><strong>Conclusions: </strong>The CE group showed an apparent reduction in biologics and surgery, limiting to L4 diagnoses. More extensive, prospective, multicentre, randomised studies must corroborate these preliminary findings.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"4 ","pages":"1038087"},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10363082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mining associations between glycemic variability in awake-time and in-sleep among non-diabetic adults. 非糖尿病成人清醒时和睡眠时血糖变异性的相关性研究。
Pub Date : 2022-11-04 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.1026830
Zilu Liang

It is often assumed that healthy people have the genuine ability to maintain tight blood glucose regulation. However, a few recent studies revealed that glucose dysregulation such as hyperglycemia may occur even in people who are considered normoglycemic by standard measures and were more prevalent than initially thought, suggesting that more investigations are needed to fully understand the within-day glucose dynamics of healthy people. In this paper, we conducted an analysis on a multi-modal dataset to examine the relationships between glycemic variability when people were awake and that when they were sleeping. The interstitial glucose levels were measured with a wearable continuous glucose monitoring (CGM) technology FreeStyle Libre 2 at every 15 min interval. In contrast to the traditional single-time-point measurements, the CGM data allow the investigation into the temporal patterns of glucose dynamics at high granularity. Sleep onset and offset timestamps were recorded daily with a Fitbit Charge 3 wristband. Our analysis leveraged the sleep data to split the glucose readings into segments of awake-time and in-sleep, instead of using fixed cut-off time points as has been done in existing literature. We combined repeated measure correlation analysis and quantitative association rules mining, together with an original post-filtering method, to identify significant and most relevant associations. Our results showed that low overall glucose in awake time was strongly correlated to low glucose in subsequent sleep, which in turn correlated to overall low glucose in the next day. Moreover, both analysis techniques identified significant associations between the minimal glucose reading in sleep and the low blood glucose index the next day. In addition, the association rules discovered in this study achieved high confidence (0.75-0.88) and lift (4.1-11.5), which implies that the proposed post-filtering method was effective in selecting quality rules.

人们通常认为,健康的人有真正的能力维持严格的血糖调节。然而,最近的一些研究表明,即使在标准测量认为血糖正常的人群中也可能发生葡萄糖失调,如高血糖症,并且比最初想象的更普遍,这表明需要更多的研究来充分了解健康人的一天内葡萄糖动态。在本文中,我们对一个多模态数据集进行了分析,以检查人们清醒时和睡眠时血糖变异性之间的关系。使用可穿戴式连续血糖监测(CGM)技术FreeStyle Libre 2每隔15分钟测量间质血糖水平。与传统的单时间点测量相比,CGM数据允许在高粒度下研究葡萄糖动力学的时间模式。每天用Fitbit Charge 3腕带记录睡眠开始和偏移时间戳。我们的分析利用睡眠数据将葡萄糖读数分成清醒时间和睡眠时间,而不是像现有文献那样使用固定的截止时间点。我们结合了重复度量相关性分析和定量关联规则挖掘,以及原始的后过滤方法,以识别重要和最相关的关联。我们的研究结果表明,清醒时的低血糖水平与随后睡眠时的低血糖水平密切相关,而睡眠时的低血糖水平又与第二天的低血糖水平相关。此外,两种分析技术都确定了睡眠中最低血糖读数与第二天低血糖指数之间的显著关联。此外,本研究发现的关联规则获得了较高的置信度(0.75 ~ 0.88)和提升度(4.1 ~ 11.5),表明本文提出的后滤波方法在质量规则的选择上是有效的。
{"title":"Mining associations between glycemic variability in awake-time and in-sleep among non-diabetic adults.","authors":"Zilu Liang","doi":"10.3389/fmedt.2022.1026830","DOIUrl":"https://doi.org/10.3389/fmedt.2022.1026830","url":null,"abstract":"<p><p>It is often assumed that healthy people have the genuine ability to maintain tight blood glucose regulation. However, a few recent studies revealed that glucose dysregulation such as hyperglycemia may occur even in people who are considered normoglycemic by standard measures and were more prevalent than initially thought, suggesting that more investigations are needed to fully understand the within-day glucose dynamics of healthy people. In this paper, we conducted an analysis on a multi-modal dataset to examine the relationships between glycemic variability when people were awake and that when they were sleeping. The interstitial glucose levels were measured with a wearable continuous glucose monitoring (CGM) technology FreeStyle Libre 2 at every 15 min interval. In contrast to the traditional single-time-point measurements, the CGM data allow the investigation into the temporal patterns of glucose dynamics at high granularity. Sleep onset and offset timestamps were recorded daily with a Fitbit Charge 3 wristband. Our analysis leveraged the sleep data to split the glucose readings into segments of awake-time and in-sleep, instead of using fixed cut-off time points as has been done in existing literature. We combined repeated measure correlation analysis and quantitative association rules mining, together with an original post-filtering method, to identify significant and most relevant associations. Our results showed that low overall glucose in awake time was strongly correlated to low glucose in subsequent sleep, which in turn correlated to overall low glucose in the next day. Moreover, both analysis techniques identified significant associations between the minimal glucose reading in sleep and the low blood glucose index the next day. In addition, the association rules discovered in this study achieved high confidence (0.75-0.88) and lift (4.1-11.5), which implies that the proposed post-filtering method was effective in selecting quality rules.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":" ","pages":"1026830"},"PeriodicalIF":0.0,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40715536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Editorial: Advances in tissue repair and regeneration. 编辑:组织修复和再生的进展。
Pub Date : 2022-11-03 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.1066486
Woojung Shin, Hyun Jung Kim
COPYRIGHT © 2022 Shin and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
{"title":"Editorial: Advances in tissue repair and regeneration.","authors":"Woojung Shin,&nbsp;Hyun Jung Kim","doi":"10.3389/fmedt.2022.1066486","DOIUrl":"https://doi.org/10.3389/fmedt.2022.1066486","url":null,"abstract":"COPYRIGHT © 2022 Shin and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":" ","pages":"1066486"},"PeriodicalIF":0.0,"publicationDate":"2022-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40698123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sourcing cells for in vitro models of human vascular barriers of inflammation. 为人类血管炎症屏障的体外模型寻找细胞。
Pub Date : 2022-10-21 eCollection Date: 2022-01-01 DOI: 10.3389/fmedt.2022.979768
Molly C McCloskey, Victor Z Zhang, S Danial Ahmad, Samuel Walker, Samantha S Romanick, Hani A Awad, James L McGrath

The vascular system plays a critical role in the progression and resolution of inflammation. The contributions of the vascular endothelium to these processes, however, vary with tissue and disease state. Recently, tissue chip models have emerged as promising tools to understand human disease and for the development of personalized medicine approaches. Inclusion of a vascular component within these platforms is critical for properly evaluating most diseases, but many models to date use "generic" endothelial cells, which can preclude the identification of biomedically meaningful pathways and mechanisms. As the knowledge of vascular heterogeneity and immune cell trafficking throughout the body advances, tissue chip models should also advance to incorporate tissue-specific cells where possible. Here, we discuss the known heterogeneity of leukocyte trafficking in vascular beds of some commonly modeled tissues. We comment on the availability of different tissue-specific cell sources for endothelial cells and pericytes, with a focus on stem cell sources for the full realization of personalized medicine. We discuss sources available for the immune cells needed to model inflammatory processes and the findings of tissue chip models that have used the cells to studying transmigration.

血管系统在炎症的进展和消退中起着关键作用。然而,血管内皮对这些过程的贡献因组织和疾病状态而异。最近,组织芯片模型已经成为了解人类疾病和开发个性化医疗方法的有前途的工具。在这些平台中包含血管成分对于正确评估大多数疾病至关重要,但迄今为止许多模型使用“通用”内皮细胞,这可能妨碍识别生物医学上有意义的途径和机制。随着血管异质性和全身免疫细胞运输知识的进步,组织芯片模型也应该在可能的情况下纳入组织特异性细胞。在这里,我们讨论了一些常见的模型组织的血管床中白细胞运输的已知异质性。我们评论了内皮细胞和周细胞的不同组织特异性细胞来源的可用性,重点是干细胞来源,以充分实现个性化医疗。我们讨论了模拟炎症过程所需的免疫细胞的可用来源,以及使用这些细胞研究转体的组织芯片模型的发现。
{"title":"Sourcing cells for <i>in vitro</i> models of human vascular barriers of inflammation.","authors":"Molly C McCloskey, Victor Z Zhang, S Danial Ahmad, Samuel Walker, Samantha S Romanick, Hani A Awad, James L McGrath","doi":"10.3389/fmedt.2022.979768","DOIUrl":"10.3389/fmedt.2022.979768","url":null,"abstract":"<p><p>The vascular system plays a critical role in the progression and resolution of inflammation. The contributions of the vascular endothelium to these processes, however, vary with tissue and disease state. Recently, tissue chip models have emerged as promising tools to understand human disease and for the development of personalized medicine approaches. Inclusion of a vascular component within these platforms is critical for properly evaluating most diseases, but many models to date use \"generic\" endothelial cells, which can preclude the identification of biomedically meaningful pathways and mechanisms. As the knowledge of vascular heterogeneity and immune cell trafficking throughout the body advances, tissue chip models should also advance to incorporate tissue-specific cells where possible. Here, we discuss the known heterogeneity of leukocyte trafficking in vascular beds of some commonly modeled tissues. We comment on the availability of different tissue-specific cell sources for endothelial cells and pericytes, with a focus on stem cell sources for the full realization of personalized medicine. We discuss sources available for the immune cells needed to model inflammatory processes and the findings of tissue chip models that have used the cells to studying transmigration.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":"4 ","pages":"979768"},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10162180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Medical Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1